Elevance Health, Inc. (ELV)
| Market Cap | 93.41B |
| Revenue (ttm) | 174.02B |
| Net Income (ttm) | 6.42B |
| Shares Out | 231.92M |
| EPS (ttm) | 27.42 |
| PE Ratio | 14.69 |
| Forward PE | 12.24 |
| Dividend | $6.52 (1.62%) |
| Ex-Dividend Date | Dec 5, 2024 |
| Volume | 1,179,401 |
| Open | 401.47 |
| Previous Close | 401.96 |
| Day's Range | 401.46 - 407.73 |
| 52-Week Range | 391.02 - 567.26 |
| Beta | 0.85 |
| Analysts | Strong Buy |
| Price Target | 543.07 (+34.84%) |
| Earnings Date | Jan 22, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates i... [Read more]
Financial Performance
In 2023, Elevance Health's revenue was $171.34 billion, an increase of 9.41% compared to the previous year's $156.60 billion. Earnings were $5.99 billion, an increase of 1.58%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for ELV stock is "Strong Buy." The 12-month stock price forecast is $543.07, which is an increase of 34.84% from the latest price.
News
Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securi...
Elevance Health, Inc. (ELV) UBS Global Healthcare Conference (Transcript)
Elevance Health, Inc. (NYSE:ELV) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Mark Kaye - Executive VP & CFO Conference Call Participants A.J. Rice - UBS A.J.
Trump Win Gives Some U.S. Health Insurers A Post-Election Bump On Wall Street
Several US health insurers saw notable stock price gains following the reelection of former US President Donald Trump amid an expectation of less federal scrutiny. Humana Inc. experienced the largest ...
Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers or others viola...
Elevance Health Announces Appearance at UBS Global Healthcare Conference
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on ...
Elevance Health Appoints Nathan Rich Vice President, Investor Relations
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich wil...
My Top 15 High-Growth Dividend Stocks For November 2024
The SPDR S&P 500 ETF Trust posted a loss of 0.89% in October, putting a pause on its strong run in 2024. The Top 15 dividend growth stocks for November 2024 offer an average dividend yield of 1.24% an...
Elevance Health Foundation Names Professional Football Player Ryan Kelly as Next Elevance Health Champion
INDIANAPOLIS--(BUSINESS WIRE)-- #maternalhealth--The Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces professional football player Ryan Kelly as its latest Elevanc...
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Bonds
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $350 million, 4.5% se...
'Overuse' is causing healthcare insurer headwinds, says Mizuho's Jared Holz
Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more.
What's Behind The 15% Fall For Elevance Health Stock?
Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus estimates. The company reported revenue of $44.7 billion and adjusted earnings ...
Elevance Health Stock: Looking Beyond Near-Term Issues, I'm A Buyer
Elevance Health's Q3 2024 results were disappointing with a significant increase in the benefit expense ratio and lowered earnings expectations for the full year. I take a close look at ELV's exposure...
These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings
Elevance Health Inc. ELV reported weaker-than-expected earnings for its third quarter on Thursday.
Elevance Health: Why Invest Over UnitedHealth Group?
Despite a disappointing Q3 report, Elevance Health remains attractive due to its relatively favorable valuation compared to UnitedHealth Group and a total shareholder yield of roughly 3.5%. Elevance's...
S&P 500 Gains and Losses Today: Health Insurers Slide as Elevance Cites Medicaid Declines
Major U.S. equities indexes were mixed as earnings results from Taiwan Semiconductor Manufacturing (TSM) helped revitalize optimism around artificial intelligence (AI) and September retail sales data ...
Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
Elevance Health's Q3 earnings report led to a 14% stock price drop due to increased benefit expense ratio and declining EPS. The health insurance industry faces challenges, particularly in Medicare Ad...
Why Is Elevance Health Stock Trading Lower On Thursday?
Elevance Health Inc. ELV reported on Thursday third-quarter revenues of $44.7 billion, up 5.3% year-over-year, beating the consensus of $43.33 billion.
Elevance Health, Inc. (ELV) Q3 2024 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q3 2024 Results Conference Call October 17, 2024 8:30 AM ET Company Participants Steve Tanal - Vice President of Investor Relations Gail Boudreaux - President and CEO...
Elevance Health Stock Sinks as Medicaid Woes Hit Earnings
Elevance Health stock is plunging Thursday after the insurer missed Q3 earnings expectations and lowered its full-year outlook. Here's what you need to know.
Elevance Health earnings: Higher medical costs weigh on profits
CNBC's Bertha Coombs reports on Elevance Health's quarterly earnings results.
Elevance Shares Dive After Insurer Faces 'Unprecedented' Medicaid Challenge
The company's earnings missed expectations, the latest sign of how medical expenses are squeezing insurers' government businesses.
Elevance Health Stock Plunges on Profit Hit From Fall in Medicaid Memberships
Elevance Health (ELV) shares cratered Thursday after the insurer posted a lower-than-expected profit and slashed its outlook on falling Medicaid enrollments.
CSX, ELV Earnings Plunge, UBER Considers EXPE Bid
Investor confidence in CSX Corporation (CSX) derailed after the company reported an earnings miss, citing issues with hurricane season. Elevance Health (ELV) beat on revenue but appears to have plunge...
Elevance Health's Q3 Earnings: Profit Falls Short Of Expectations On Higher Medical Costs, Issues Soft Annual Outlook
On Thursday, Elevance Health Inc. ELV reported third-quarter revenues of $44.7 billion, up 5.3% year-over-year, beating the consensus of $43.33 billion.